This 2004 review outlines the use of subcutaneous estradiol pellet implants for estrogen replacement therapy in postmenopausal women. The procedure involves a minor office-based insertion of 25 mg estradiol pellets into the lower abdomen or buttocks. This method achieves physiologic estradiol levels and suppresses follicle-stimulating hormone (FSH), mirroring premenopausal hormonal
This review examines the effects of standard and low-dose hormone therapy (HT) on postmenopausal women, particularly in relation to breast health. HT remains the most effective treatment for menopausal symptoms, though prolonged use of estrogen-progestogen therapy (EPT) may slightly increase breast cancer risk, which diminishes after discontinuation. Low-dose HT provides
This study examines the effects of low-dose hormone replacement therapy (HRT) on bone health in postmenopausal women. It found that low-dose HRT effectively alleviates climacteric symptoms while minimizing side effects like unscheduled bleeding. Additionally, when combined with calcium supplementation, it helps prevent bone loss, reducing the risk of osteoporosis in
This systematic review assesses the safety and effectiveness of low-dose oral continuous combined hormone therapy (cc-HT) for managing climacteric symptoms in postmenopausal women. It finds that low-dose cc-HT effectively alleviates symptoms and prevents bone loss with a favorable safety profile, showing no increased risks for cardiovascular diseases or breast cancer.
